Enhanced Stability and Improved Oral Absorption of Enzalutamide with Self-Nanoemulsifying Drug Delivery System
Open Access
- 18 January 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (2) , 1197
Abstract
The purpose of this study is to develop and evaluate a self-nanoemulsifying drug delivery system (SNEDDS) to improve the oral absorption of poorly water-soluble enzalutamide (ENZ). Considering the rapid recrystallization of the drug, based on solubility and crystallization tests in various oils, surfactants and co-surfactants, Labrafac PG 10%, Solutol HS15 80%, and Transcutol P 10%, which showed the most stable particle size and polydispersity index (PDI) without drug precipitation, were selected as the optimal SNEDDS formulation. The optimized SNEDDS formulation showed excellent dissolution profiles for all the drugs released at 10 min of dissolution due to the increased surface area with a small particle size of approximately 16 nm. Additionally, it was confirmed to be stable without significant differences in physical and chemical properties for 6 months under accelerated conditions (40 ± 2 °C, 75 ± 5% RH) and stressed conditions (60 ± 2 °C). Associated with the high dissolutions of ENZ, pharmacokinetic parameters were also greatly improved. Specifically, the AUC was 1.9 times higher and the Cmax was 1.8 times higher than those of commercial products (Xtandi® soft capsule), resulting in improved oral absorption. Taken together with the results mentioned above, the SNEDDS could be an effective tool as a formulation for ENZ and other similar drugs.Keywords
Funding Information
- National Research Foundation of Korea (2021R1F1A1063123)
This publication has 28 references indexed in Scilit:
- Lipid-based formulations for oral administration of poorly water-soluble drugsInternational Journal of Pharmaceutics, 2013
- Influence of Additives on the Properties of Nanodroplets Formed in Highly Supersaturated Aqueous Solutions of RitonavirMolecular Pharmaceutics, 2013
- Solid dispersions: a strategy for poorly aqueous soluble drugs and technology updatesExpert Opinion on Drug Delivery, 2012
- The Solubility–Permeability Interplay and Its Implications in Formulation Design and Development for Poorly Soluble DrugsThe AAPS Journal, 2012
- Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptorProceedings of the National Academy of Sciences, 2010
- Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral DrugsThe AAPS Journal, 2009
- Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate CancerScience, 2009
- Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administrationAdvanced Drug Delivery Reviews, 2008
- Drug delivery strategies for poorly water-soluble drugsExpert Opinion on Drug Delivery, 2007
- Oral lipid-based formulationsAdvanced Drug Delivery Reviews, 2007